Source: Annual Congress 2013 –Pneumonia and sepsis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gündüz, M. S. Tasbakan, A. Sayiner, A. çilli, B. Karaboga, O. Kilinç, O. Kiliç, A. Sakar Coskun, C. çetinkaya, A. Hazar, F. Tokgöz (Izmir, Antalya, Manisa, Istanbul, Turkey). Factors affecting treatment success in community acquired pneumonia (CAP). Eur Respir J 2013; 42: Suppl. 57, 299

Member's Comments

No comment yet.

Related content which might interest you: The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Modification of empirical antibiotic therapy in community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Fatal outcomes in patients with community acquired pneumonia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Factors affecting short and long-term mortality after community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Risk factors for pleural complications in children with community acquired pneumonia Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia? Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Predictors of length of stay in hospitalized patients with community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Early discharge of community acquired pneumonia (CAP) patients with community respiratory assessment services (RAS) follow up in a UK DGH Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Surfactant-enforced treatment of pseudomonas-induced pneumonia Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Severity scores and management of community acquired pneumonia Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Development of an antibody therapy for the treatment of pneumonia Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016